Pages that link to "Q51974599"

The following pages link to Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases (Q51974599):

Displaying 27 items.

• Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma (Q26800554) (← links)
• Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium (Q26828479) (← links)
• Expression of glypican 3 in placental site trophoblastic tumor (Q34199179) (← links)
• Glypican-3: A new target for cancer immunotherapy (Q34543102) (← links)
• Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma (Q35656544) (← links)
• Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors (Q35690288) (← links)
• Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver (Q36598885) (← links)
• Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma (Q37031710) (← links)
• Glypican-3 antibodies: a new therapeutic target for liver cancer (Q37625736) (← links)
• Current issues and controversies in the classification of pediatric hepatocellular tumors (Q38014789) (← links)
• Genetics and epigenetics of hepatoblastoma. (Q38027114) (← links)
• Glypican-3 protein expression in primary and metastatic melanoma: a combined immunohistochemistry and immunocytochemistry study (Q38421224) (← links)
• Hepatocellular Malignant Neoplasm-NOS: A Clinicopathologic Study of 11 Cases from a Single Institution. (Q39404128) (← links)
• New tumor suppressor microRNAs target glypican-3 in human liver cancer. (Q41093562) (← links)
• Glypican 3 as a Serum Marker for Hepatoblastoma (Q42003901) (← links)
• Teratoid hepatoblastoma with abundant cholangioblastic component in a child with full trisomy 13. (Q44858897) (← links)
• Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity (Q45857417) (← links)
• Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution (Q46405678) (← links)
• Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors (Q47118215) (← links)
• A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma (Q48091492) (← links)
• Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases (Q48109824) (← links)
• An infant with a diagnostically challenging hepatic teratoma, hypofibrinogenemia, and adrenal neuroblastoma: case report (Q51046731) (← links)
• Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma. (Q53382084) (← links)
• A patient with Simpson-Golabi-Behmel syndrome, biliary cirrhosis and successful liver transplantation. (Q54414245) (← links)
• Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors (Q64100737) (← links)
• Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients (Q84310453) (← links)
• Glypican 3 overexpression in primary and metastatic Wilms tumors (Q85902702) (← links)